ArticleChest2022
The Vexing Voyage of Vasopressin: The Consequences of Granting Market Exclusivity to Unapproved Drugs.
Liam Bendicksen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papercites it
ArticleChest2022
Liam Bendicksen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.